This NHIA member resource page provides helpful reference, information, and tools related to the January 1, 2017, implementation of Average Sales Price (ASP) reimbursement that was included as part of the 21st Century Cures Act. It is a starting point to considering the coverage and payment issues for home infusion therapy under the new payment system. Here you will also find the tools to assist you in rallying behind the effort to close the gap between ASP reimbursement and Part B Durable Medical Equipment (DME) Coverage of home infusion services while also working to attain a services and supplies payment for Part D infusion drugs.
NHIA has created a reference tool that compares current Average Wholesale Price (AWP)-based coverage to ASP-based coverage. The spreadsheet will automatically download for NHIA members by clicking here.
NHIA Coalition Sign-on Letter to Fix ASP Medicare Part B DME Infusion Drugs Reimbursement Gap
Talking Points: Closing the Gap Between ASP Reimbursement and a Services Payment
for Medicare Part B DME Infusion Drugs
Op-Ed Guideline: Writing an op-ed on importance of Closing the ASP Reimbursement/Services Payment Gap for Medicare Part B DME Infusion Drugs
Sample Letter: FIAC Asking Partners for Support on ASP Reimbursement
Sample Letter: Home Infusion Providers to Beneficiaries
Sample Letter: Home Infusion Providers to Physicians & Referral Sources
Copyright ©2017 National Home Infusion Association